日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical application of glucagon-like Peptide 1 receptor agonists for the treatment of type 2 diabetes mellitus

胰高血糖素样肽-1受体激动剂在治疗2型糖尿病中的临床应用

Cho, Young Min; Wideman, Rhonda D; Kieffer, Timothy J

Leptin therapy reverses hyperglycemia in mice with streptozotocin-induced diabetes, independent of hepatic leptin signaling

瘦素疗法可逆转链脲佐菌素诱导糖尿病小鼠的高血糖症,且与肝脏瘦素信号传导无关。

Denroche, Heather C; Levi, Jasna; Wideman, Rhonda D; Sequeira, Roveena M; Huynh, Frank K; Covey, Scott D; Kieffer, Timothy J

Production of functional glucagon-secreting α-cells from human embryonic stem cells.

利用人类胚胎干细胞生产功能性胰高血糖素分泌α细胞

Rezania Alireza, Riedel Michael J, Wideman Rhonda D, Karanu Francis, Ao Ziliang, Warnock Garth L, Kieffer Timothy J

Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 (GLP-1).

通过内源性产生胰高血糖素样肽 1 (GLP-1) 来改善胰岛的功能和存活率

Wideman Rhonda D, Yu Irene L Y, Webber Travis D, Verchere C Bruce, Johnson James D, Cheung Anthony T, Kieffer Timothy J